Goffin JR - Search Results

1

Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer.

Foulkes WD, Stefansson IM, Chappuis PO, Bégin LR, Goffin JR, Wong N, Trudel M, Akslen LA. Foulkes WD, et al. Among authors: goffin jr. J Natl Cancer Inst. 2003 Oct 1;95(19):1482-5. doi: 10.1093/jnci/djg050. J Natl Cancer Inst. 2003. PMID: 14519755

2

Re: Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer.

Goffin J, Chappuis PO, Wong N, Foulkes WD. Goffin J, et al. J Natl Cancer Inst. 2001 Nov 21;93(22):1754-5. doi: 10.1093/jnci/93.22.1754. J Natl Cancer Inst. 2001. PMID: 11717339 No abstract available.

3

Change in the penetrance of founder BRCA1/2 mutations? A retrospective cohort study.

Foulkes WD, Brunet JS, Wong N, Goffin J, Chappuis PO. Foulkes WD, et al. J Med Genet. 2002 Jun;39(6):407-9. doi: 10.1136/jmg.39.6.407. J Med Genet. 2002. PMID: 12070248 Free PMC article. No abstract available.

4

A significant response to neoadjuvant chemotherapy in BRCA1/2 related breast cancer.

Chappuis PO, Goffin J, Wong N, Perret C, Ghadirian P, Tonin PN, Foulkes WD. Chappuis PO, et al. J Med Genet. 2002 Aug;39(8):608-10. doi: 10.1136/jmg.39.8.608. J Med Genet. 2002. PMID: 12161606 Free PMC article. No abstract available.

5

Tamoxifen may be an effective adjuvant treatment for BRCA1-related breast cancer irrespective of estrogen receptor status.

Foulkes WD, Goffin J, Brunet JS, Bégin LR, Wong N, Chappuis PO. Foulkes WD, et al. J Natl Cancer Inst. 2002 Oct 2;94(19):1504-6. doi: 10.1093/jnci/94.19.1504-a. J Natl Cancer Inst. 2002. PMID: 12359859 No abstract available.

6

Prognostic importance of glomeruloid microvascular proliferation indicates an aggressive angiogenic phenotype in human cancers.

Straume O, Chappuis PO, Salvesen HB, Halvorsen OJ, Haukaas SA, Goffin JR, Bégin LR, Foulkes WD, Akslen LA. Straume O, et al. Among authors: goffin jr. Cancer Res. 2002 Dec 1;62(23):6808-11. Cancer Res. 2002. PMID: 12460889

7

Impact of germline BRCA1 mutations and overexpression of p53 on prognosis and response to treatment following breast carcinoma: 10-year follow up data.

Goffin JR, Chappuis PO, Bégin LR, Wong N, Brunet JS, Hamel N, Paradis AJ, Boyd J, Foulkes WD. Goffin JR, et al. Cancer. 2003 Feb 1;97(3):527-36. doi: 10.1002/cncr.11080. Cancer. 2003. PMID: 12548593 Free article.

8

Glomeruloid microvascular proliferation is associated with p53 expression, germline BRCA1 mutations and an adverse outcome following breast cancer.

Goffin JR, Straume O, Chappuis PO, Brunet JS, Bégin LR, Hamel N, Wong N, Akslen LA, Foulkes WD. Goffin JR, et al. Br J Cancer. 2003 Sep 15;89(6):1031-4. doi: 10.1038/sj.bjc.6601195. Br J Cancer. 2003. PMID: 12966421 Free PMC article.

9

A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment.

Robson ME, Chappuis PO, Satagopan J, Wong N, Boyd J, Goffin JR, Hudis C, Roberge D, Norton L, Bégin LR, Offit K, Foulkes WD. Robson ME, et al. Among authors: goffin jr. Breast Cancer Res. 2004;6(1):R8-R17. doi: 10.1186/bcr658. Epub 2003 Oct 24. Breast Cancer Res. 2004. PMID: 14680495 Free PMC article.

10

The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer.

Foulkes WD, Brunet JS, Stefansson IM, Straume O, Chappuis PO, Bégin LR, Hamel N, Goffin JR, Wong N, Trudel M, Kapusta L, Porter P, Akslen LA. Foulkes WD, et al. Among authors: goffin jr. Cancer Res. 2004 Feb 1;64(3):830-5. doi: 10.1158/0008-5472.can-03-2970. Cancer Res. 2004. PMID: 14871808

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters